{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:27:17Z","timestamp":1780374437417,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Cairo University (EG), Faculty of Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s11010-019-03506-x","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T06:24:44Z","timestamp":1550471084000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy"],"prefix":"10.1007","volume":"457","author":[{"given":"Hanan H.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma M.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2887-5007","authenticated-orcid":false,"given":"Heba S.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Elwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Abdelnasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"key":"3506_CR1","doi-asserted-by":"publisher","unstructured":"Diabetes Care (2018) 41(Supplement 1): S1\u2013S2. \n                    https:\/\/doi.org\/10.2337\/dc18-Sint01","DOI":"10.2337\/dc18-Sint01"},{"issue":"6","key":"3506_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","volume":"71","author":"K Umanath","year":"2018","unstructured":"Umanath K, Lewis J (2018) Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis 71(6):884\u2013895","journal-title":"Am J Kidney Dis"},{"issue":"9866","key":"3506_CR3","first-page":"532","volume":"381","author":"B Mahmoodi","year":"2013","unstructured":"Mahmoodi B, Fox C, Astor B, Nelson R, Matsushita K, Coresh J (2013) Association of chronic kidney disease with adverse outcomes. Chronic Kidney Dis 381(9866):532\u2013533","journal-title":"Chronic Kidney Dis"},{"issue":"10","key":"3506_CR4","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.2337\/dbi16-0042","volume":"65","author":"W Durante","year":"2016","unstructured":"Durante W (2016) Hydrogen sulfide therapy in diabetes-accelerated atherosclerosis: a whiff of success. Diabetes 65(10):2832\u20132834. \n                    https:\/\/doi.org\/10.2337\/dbi16-0042","journal-title":"Diabetes"},{"issue":"6825","key":"3506_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/35065638","volume":"410","author":"HA Tissenbaum","year":"2001","unstructured":"Tissenbaum HA, Guarente L (2001) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410(6825):227\u2013230","journal-title":"Nature"},{"key":"3506_CR6","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1101\/gad.227439.113","volume":"27","author":"L Guarente","year":"2013","unstructured":"Guarente L (2013) Calorie restriction and sirtuins revisited. Genes Dev 27:2072\u20132085","journal-title":"Genes Dev"},{"issue":"7","key":"3506_CR7","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.2337\/db13-1810","volume":"63","author":"R Liu","year":"2014","unstructured":"Liu R, Zhong Y, Li X (2014) Role of transcription factor acetylation in diabetic kidney disease. Diabetes 63(7):2440\u20132453","journal-title":"Diabetes"},{"issue":"3","key":"3506_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1042\/CS20120190","volume":"124","author":"M Kitada","year":"2013","unstructured":"Kitada M, Kume S, Takeda-Watanabe A, Kanasaki K, Koya D (2013) Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin Sci 124(3):153\u2013164","journal-title":"Clin Sci"},{"issue":"4","key":"3506_CR9","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1172\/JCI41563","volume":"120","author":"W He","year":"2010","unstructured":"He W, Wang Y, Zhang MZ, You L, Davis LS, Fan H, Yang HC, Fogo AB, Zent R, Harris RC, Breyer MD, Hao CM (2010) Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 120(4):1056\u20131068","journal-title":"J Clin Invest"},{"issue":"2","key":"3506_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3109\/0886022X.2013.844644","volume":"36","author":"J Liang","year":"2014","unstructured":"Liang J, Tian S, Han J, Xiong P (2014) Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction. Ren Fail 36(2):285\u2013291","journal-title":"Ren Fail"},{"key":"3506_CR11","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1101\/gad.1901210","volume":"24","author":"AK Walker","year":"2010","unstructured":"Walker AK, Yang F, Jiang K, Ji JY, Watts JL, Purushotham A, Boss O, Hirsch ML, Ribich S, Smith JJ (2010) Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid\/cholesterol regulator SREBP. Genes Dev 24:1403\u20131417","journal-title":"Genes Dev"},{"key":"3506_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/908185","author":"M Kitada","year":"2011","unstructured":"Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K, Koya D (2011) Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa\/fa) rats: a model of type 2 diabetes. Exp Diabetes Res \n                    https:\/\/doi.org\/10.1155\/2011\/908185","journal-title":"Exp Diabetes Res"},{"key":"3506_CR13","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/ATVBAHA.108.166991","volume":"28","author":"R Miyazaki","year":"2008","unstructured":"Miyazaki R, Ichiki T, Hashimoto T, Inanaga K, Imayama I, Sadoshima J, Sunagawa K (2008) SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 28:1263\u20131269","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3506_CR14","doi-asserted-by":"crossref","unstructured":"De Morais H, de Souza CP, da Silva LM, Ferreira DM, Werner MF, Andreatini R, da Cunha JM, Zanoveli JM. Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats. Behav Brain Res 258:52\u201364","DOI":"10.1016\/j.bbr.2013.10.011"},{"issue":"5","key":"3506_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/FBP.0000000000000143","volume":"26","author":"Z Tang","year":"2015","unstructured":"Tang Z, Wei Z, Juan Y, Ping Z, Yin T, Zhi-Fang X, Mang-Hong L, Hai-Jun W, Xiao-Qing T (2015) Antidepressant-like and anxiolytic-like effects of hydrogen sulfide in streptozotocin-induced diabetic rats through inhibition of hippocampal oxidative stress. Behav Pharmacol 26(5):427\u2013435","journal-title":"Behav Pharmacol"},{"issue":"2","key":"3506_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/jcp.22.2.158","volume":"22","author":"P Trinder","year":"1969","unstructured":"Trinder P (1969) Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 22(2):158\u2013161","journal-title":"J Clin Pathol"},{"issue":"10","key":"3506_CR17","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/clinchem\/21.10.1422","volume":"21","author":"GA Moss","year":"1975","unstructured":"Moss GA, Bondar RJ, Buzzelli DM (1975) Kinetic enzymatic method for determining serum creatinine. Clin Chem 21(10):1422\u20131426","journal-title":"Clin Chem"},{"key":"3506_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/000456329002700404","volume":"4","author":"DJ Rowe","year":"1990","unstructured":"Rowe DJ, Dawnay A, Watts GF (1990) Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine. Ann Clin Biochem 4:297\u2013312","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"3506_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0003-2697(71)90370-8","volume":"44","author":"C Beauchamp","year":"1971","unstructured":"Beauchamp C, Fridovich I (1971) Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 44(1):276\u2013287","journal-title":"Anal Biochem"},{"key":"3506_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02540959","volume":"15","author":"T Asakawa","year":"1979","unstructured":"Asakawa T, Matsushita S (1979) Lipids 15:137\u2013140","journal-title":"Lipids"},{"issue":"3","key":"3506_CR21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1124\/jpet.108.149963","volume":"329","author":"M Xia","year":"2009","unstructured":"Xia M, Chen L, Muh RW, Li PL, Li N (2009) Production and actions of hydrogen sulfide, a novel gaseous bioactive substance in the kidneys. J Pharmacol Exp Ther 329(3):1056\u20131062","journal-title":"J Pharmacol Exp Ther"},{"key":"3506_CR22","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ncomms2371","volume":"4","author":"N Shibuya","year":"2013","unstructured":"Shibuya N, Koike S, Tanaka M, Ishigami-Yuasa M, Kimura Y, Ogasawara Y (2013) A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nat Commun 4:1366","journal-title":"Nat Commun"},{"issue":"8","key":"3506_CR23","doi-asserted-by":"publisher","first-page":"e0136113","DOI":"10.1371\/journal.pone.0136113","volume":"10","author":"GJ Dugbartey","year":"2015","unstructured":"Dugbartey GJ, Bouma HR, Strijkstra AM, Boerema AS, Henning HR (2015) Induction of a torpor-like state by 5\u2032-AMP does not depend on H2S production. PLoS ONE 10(8):e0136113","journal-title":"PLoS ONE"},{"key":"3506_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ejphar.2015.11.022","volume":"769","author":"GJ Dugbartey","year":"2015","unstructured":"Dugbartey GJ, Talaei F, Houwertjes MC (2015) Dopamine treatment attenuates acute kidney injury in a rat model of deep hypothermia and rewarming \u2013 The role of renal H2S-producing enzymes. Eur J Pharmacol 769:225\u2013233","journal-title":"Eur J Pharmacol"},{"key":"3506_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.niox.2014.10.002","volume":"42","author":"PM Snijder","year":"2014","unstructured":"Snijder PM, Frenay AR, Koning AM (2014) Sodium thiosulfate attenuates angiotensinII-induced hypertension, proteinuria and renal damage. Nitric Oxide 42:87\u201398","journal-title":"Nitric Oxide"},{"issue":"11","key":"3506_CR26","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1089\/ars.2009.2956","volume":"12","author":"SK Jain","year":"2010","unstructured":"Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S, McVie R, Bocchini JA (2010) Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal 12(11):1333\u20131337","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3506_CR27","doi-asserted-by":"publisher","first-page":"S483","DOI":"10.12980\/APJTB.4.201414B58","volume":"4","author":"M Dutta","year":"2014","unstructured":"Dutta M, Biswas UK, Chakraborty R, Banerjee P, Raychaudhuri U, Kumar A (2014) Evaluation of plasma H2S levels and H2S synthesis in streptozotocin induced Type-2 diabetes-an experimental study based on Swietenia macrophylla seeds. Asian Pac J Trop Biomed 4(1):S483\u2013S487","journal-title":"Asian Pac J Trop Biomed"},{"issue":"42","key":"3506_CR28","doi-asserted-by":"publisher","first-page":"28827","DOI":"10.1074\/jbc.M114.596593","volume":"289","author":"X Zhou","year":"2014","unstructured":"Zhou X, Feng Y, Zhan Z, Chen J (2014) Hydrogen sulfide alleviates diabetic nephropathy on a streptozotocin-induced diabetic rat model. J Biol Chem 289(42):28827\u201328834t","journal-title":"J Biol Chem"},{"issue":"1","key":"3506_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/ars.2012.5024","volume":"19","author":"R Xue","year":"2013","unstructured":"Xue R, Hao D-D, Sun J-P, Li W-W, Zhao M-M, Li X-H, Zhu Y-C (2013) Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes. Antioxid Redox Signal 19(1):5\u201323. \n                    https:\/\/doi.org\/10.1089\/ars.2012.5024","journal-title":"Antioxid Redox Signal"},{"key":"3506_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/162724","author":"D Cheng","year":"2013","unstructured":"Cheng D, Liang B, Li Y (2013) Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats. Biomed Res Int. \n                    https:\/\/doi.org\/10.1155\/2013\/162724","journal-title":"Biomed Res Int"},{"issue":"1","key":"3506_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pharep.2014.08.001","volume":"67","author":"MM Safar","year":"2015","unstructured":"Safar MM, Abdelsalam RM (2015) H2S donors attenuate diabetic nephropathy in rats: modulation of oxidant status and polyol pathway. Pharmacol Rep 67(1):17\u201323","journal-title":"Pharmacol Rep"},{"issue":"7","key":"3506_CR32","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/ndt\/gfq749","volume":"26","author":"P Yuan","year":"2011","unstructured":"Yuan P, Xue H, Zhou L, Qu L, Li C, Wang Z (2011) Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. Nephrol Dial Transplant 26(7):2119\u20132126","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"3506_CR33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.bbrc.2016.03.154","volume":"473","author":"X Qian","year":"2016","unstructured":"Qian X, Li X, Ma F, Luo S, Ge R, Zhu Y (2016) Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy. Biochem Biophys Res Commun 473(4):931\u2013938","journal-title":"Biochem Biophys Res Commun"},{"key":"3506_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40200-015-0185-7","volume":"14","author":"M Kaur","year":"2015","unstructured":"Kaur M, Sachdeva S, Bedi O, Kaur T, Kumar P (2015) Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats. J Diabetes Metab Disord 14:63","journal-title":"J Diabetes Metab Disord"},{"key":"3506_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1475-2840-4-3","volume":"4","author":"H Chen","year":"2005","unstructured":"Chen H, Brahmbhatt S, Gupta A, Sharma AC (2005) Duration of streptozotocin-induced diabetes differentially affects p\u00a038-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction. Cardiovasc Diabetol 4:3","journal-title":"Cardiovasc Diabetol"},{"key":"3506_CR36","first-page":"1215","volume":"286","author":"V Vallon","year":"1998","unstructured":"Vallon V, Albinus M, Blach D (1998) Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats. J Pharmacol Exp Ther 286:1215","journal-title":"J Pharmacol Exp Ther"},{"key":"3506_CR37","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2337\/diabetes.53.3.735","volume":"53","author":"MA Nobrega","year":"2004","unstructured":"Nobrega MA, Fleming S, Roman RJ, Shiozawa M, Schlick N, Lazar J, Jacob HJ (2004) Initial characterization of a rat model of diabetic nephropathy. Diabetes 53:735","journal-title":"Diabetes"},{"key":"3506_CR38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jss.2004.08.001","volume":"123","author":"RG Casey","year":"2005","unstructured":"Casey RG, Joyce M, Roche-Nagle G, Chen G, Bouchier-Hayes D (2005) Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease. J Surg Res 123:176\u2013181","journal-title":"J Surg Res"},{"key":"3506_CR39","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1096\/fasebj.2.8.3282959","volume":"2","author":"MP O\u2019Donnell","year":"1988","unstructured":"O\u2019Donnell MP, Kasiske BL, Keane WF (1988) Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J 2:2339","journal-title":"FASEB J"},{"key":"3506_CR40","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1007\/s00125-010-1810-0","volume":"53","author":"A Kuwabara","year":"2010","unstructured":"Kuwabara A, Satoh M, Tomita N (2010) Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 53:2056\u20132065","journal-title":"Diabetologia"},{"key":"3506_CR41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/00041552-199511000-00009","volume":"4","author":"RD Toto","year":"1995","unstructured":"Toto RD (1995) Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance. Curr Opin Nephr Hypertens 4:505\u2013509","journal-title":"Curr Opin Nephr Hypertens"},{"key":"3506_CR42","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/clinchem\/38.10.1933","volume":"38","author":"RD Perrone","year":"1992","unstructured":"Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38:1933\u20131953","journal-title":"Clin Chem"},{"key":"3506_CR43","unstructured":"Shemesh O, Golbetz H, Kriss JP, Myers BD.(1985):Limitations of creatinine as a Kidney Int.28(5):830\u2013838"},{"key":"3506_CR44","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1365-2362.2004.01429.x","volume":"34","author":"G Wolf","year":"2004","unstructured":"Wolf G (2004) New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Investig 34:785\u2013796","journal-title":"Eur J Clin Investig"},{"key":"3506_CR45","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/S0140-6736(00)04728-0","volume":"357","author":"P Ruggenenti","year":"2001","unstructured":"Ruggenenti P, Schieppati A, Remuzzi G (2001) Progression, remission, regression of chronic renal diseases. The Lancet 357:1601\u20131608","journal-title":"The Lancet"},{"issue":"1","key":"3506_CR46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10157-012-0670-y","volume":"17","author":"J Yamamoto","year":"2013","unstructured":"Yamamoto J, Sato W, Kosugi T, Yamamoto T, Kimura T, Taniguchi S (2013) Distribution of hydrogen sulfide (H2S)-producing enzymes and the roles of the H2S donor sodium hydrosulfide in diabetic nephropathy. Clin Exp Nephrol 17(1):32\u201340","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"3506_CR47","doi-asserted-by":"publisher","first-page":"e23566","DOI":"10.1371\/journal.pone.0023566","volume":"6","author":"P Chuang","year":"2011","unstructured":"Chuang P, Dai Y, Liu R, He H, Kretzler M, Jim B (2011) Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS ONE 6(8):e23566","journal-title":"PLoS ONE"},{"issue":"6","key":"3506_CR48","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/CIRCRESAHA.111.243592","volume":"109","author":"S Zhou","year":"2011","unstructured":"Zhou S, Chen H, Wan Y, Zhang Q, Wei Y, Huang S, Liu J, Lu J, Zhang Z, Yang R, Zhang R, Cai H, Liu D, Liang C (2011) Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res 109(6):639\u2013648","journal-title":"Circ Res"},{"key":"3506_CR49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fendo.2014.00166","volume":"5","author":"R Yacoub","year":"2014","unstructured":"Yacoub R, Lee K, He JC (2014) The role of SIRT1 in diabetic kidney disease. Front Endocrinol 5:166","journal-title":"Front Endocrinol"},{"key":"3506_CR50","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00125-012-2747-2","volume":"56","author":"MY Kim","year":"2013","unstructured":"Kim MY, Lim JH, Youn HH, Hong YA, Yang KS, Park HS, Chung S, Ko SH, Shin SJ, Choi BS, Kim HW, Kim YS, Lee JH, Chang YS, Park CW (2013) Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT-1-PGC1a axis in db\/db mice. Diabetologia 56:204\u2013217","journal-title":"Diabetologia"},{"key":"3506_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/10715760801998646","volume":"42","author":"K Tikoo","year":"2008","unstructured":"Tikoo K, Singh K, Kabra D, Sharma V, Gaikwad A (2008) Change in histoneH3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy. Free Radic Res 42:397\u2013404, 2008","journal-title":"Free Radic Res"},{"issue":"30","key":"3506_CR52","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10157-011-0418-0","volume":"15","author":"S Maeda","year":"2011","unstructured":"Maeda S, Koya D, Araki S (2011) Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes. Clin Exp Nephrol 15(30):381\u2013390","journal-title":"Clin Exp Nephrol"},{"issue":"24","key":"3506_CR53","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.2174\/0929867322666150625095407","volume":"22","author":"C Hu","year":"2015","unstructured":"Hu C, Sun L, Xiao L, Han Y, Fu X, Xiong X (2015) Insights into the mechanisms involved in the expression and regulation of extracellular matrix proteins in diabetic nephropathy. Curr Med Chem 22(24):2858\u20132870","journal-title":"Curr Med Chem"},{"key":"3506_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12882-015-0156-8","volume":"16","author":"K Guo","year":"2015","unstructured":"Guo K, Lu J, Kou J, Wu M, Zhang L, Yu H (2015) Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy. BMC Nephrol 16:159","journal-title":"BMC Nephrol"},{"key":"3506_CR55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.niox.2015.02.003","volume":"46","author":"S Kundu","year":"2015","unstructured":"Kundu S, Pushpakumar S, Sen U (2015) MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator. Nitric Oxide 46:172\u2013185","journal-title":"Nitric Oxide"},{"key":"3506_CR56","doi-asserted-by":"publisher","first-page":"135e142","DOI":"10.4067\/S0717-95022010000100019","volume":"28","author":"M Zafar","year":"2010","unstructured":"Zafar M, Naqvi SN (2010) Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: a comparative study. Int J Morphol 28:135e142","journal-title":"Int J Morphol"},{"key":"3506_CR57","doi-asserted-by":"publisher","first-page":"30292","DOI":"10.1038\/srep30292","volume":"6","author":"W Wang","year":"2016","unstructured":"Wang W, Cai G, Ning Y, Cui J, Hong Q, Bai X, Chen X (2016) Hydrogen sulfide mediates the protection of dietary restriction against renal senescence in aged F344 rats. Sci Rep 6:30292","journal-title":"Sci Rep"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03506-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03506-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03506-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T10:48:42Z","timestamp":1582022922000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03506-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,18]]},"references-count":57,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["3506"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03506-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,18]]},"assertion":[{"value":"17 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}